Sign in

CIK 0001590750 · Large accelerated filer

Viridian Therapeutics, Inc.\DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471187261
Phone
617.272.4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. S-1/A Offering Registration Statement
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. CERTNAS Other Certification by the Nasdaq Stock Market
  15. 8-A12B Other Registration of Securities
  16. S-1/A Offering Registration Statement
  17. FWP Offering Free Writing Prospectus
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. S-1/A Offering Registration Statement
  20. UPLOAD Other SEC-generated Letter

Page 40 of 41 · 819 filings